Literature DB >> 12076559

An epidemic Burkholderia cepacia complex strain identified in soil.

John J LiPuma1, Theodore Spilker, Tom Coenye, Carlos F Gonzalez.   

Abstract

Life threatening infection with species of the Burkholderia cepacia complex frequently occurs as a result of cross infection among individuals with cystic fibrosis. Stringent infection control measures have decreased but not eliminated such infection in this vulnerable population, implying that non-patient reservoirs contribute to ongoing acquisition. However, strains common to both the natural environment and patients with cystic fibrosis have not yet been described. By use of various genotyping methods, we have identified from agricultural soil the B cepacia genomovar III strain that is most frequently recovered from cystic fibrosis patients in the mid-Atlantic region of the USA. This finding indicates that human pathogenic strains are not necessarily distinct from environmental strains, and might help explain ongoing human acquisition despite strict infection control measures.

Entities:  

Mesh:

Year:  2002        PMID: 12076559     DOI: 10.1016/S0140-6736(02)08836-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  68 in total

Review 1.  Recent advances in cross-infection in cystic fibrosis: Burkholderia cepacia complex, Pseudomonas aeruginosa, MRSA and Pandoraea spp.

Authors:  Andrew M Jones; A Kevin Webb
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

2.  Ecological succession in long-term experimentally evolved biofilms produces synergistic communities.

Authors:  Steffen R Poltak; Vaughn S Cooper
Journal:  ISME J       Date:  2010-09-02       Impact factor: 10.302

Review 3.  A decade of Burkholderia cenocepacia virulence determinant research.

Authors:  Slade A Loutet; Miguel A Valvano
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

4.  Mapping the Burkholderia cenocepacia niche response via high-throughput sequencing.

Authors:  D R Yoder-Himes; P S G Chain; Y Zhu; O Wurtzel; E M Rubin; James M Tiedje; R Sorek
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-20       Impact factor: 11.205

5.  Species abundance and diversity of Burkholderia cepacia complex in the environment.

Authors:  Alban Ramette; John J LiPuma; James M Tiedje
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

Review 6.  Burkholderia cepacia Complex Bacteria: a Feared Contamination Risk in Water-Based Pharmaceutical Products.

Authors:  Mariana Tavares; Mariya Kozak; Alexandra Balola; Isabel Sá-Correia
Journal:  Clin Microbiol Rev       Date:  2020-04-15       Impact factor: 26.132

7.  Naturally occurring Class A ss-lactamases from the Burkholderia cepacia complex.

Authors:  Laurent Poirel; José-Manuel Rodriguez-Martinez; Patrick Plésiat; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

8.  Use of Synthetic Hybrid Strains To Determine the Role of Replicon 3 in Virulence of the Burkholderia cepacia Complex.

Authors:  Kirsty Agnoli; Roman Freitag; Margarida C Gomes; Christian Jenul; Angela Suppiger; Olga Mannweiler; Carmen Frauenknecht; Daniel Janser; Annette C Vergunst; Leo Eberl
Journal:  Appl Environ Microbiol       Date:  2017-06-16       Impact factor: 4.792

9.  Factors influencing acquisition of Burkholderia cepacia complex organisms in patients with cystic fibrosis.

Authors:  Kay A Ramsay; Claire A Butler; Stuart Paynter; Robert S Ware; Timothy J Kidd; Claire E Wainwright; Scott C Bell
Journal:  J Clin Microbiol       Date:  2013-09-18       Impact factor: 5.948

10.  Bacterial defenses against a natural antibiotic promote collateral resilience to clinical antibiotics.

Authors:  Lucas A Meirelles; Elena K Perry; Megan Bergkessel; Dianne K Newman
Journal:  PLoS Biol       Date:  2021-03-10       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.